As shown in Figure1Aiii and1B, BRCA1-mutated breast cancer exhibited global promoter hypermethylation (P = 0.044; Figure1D), especially around the E2F1 motif (P = 0.017; Figure1C). This evidence concerns the gene E2F1 and breast carcinoma.